NICLF yields 1694.92% · PFE yields 6.13%● Live data
📍 NICLF pulled ahead of the other in Year 1
Combined, NICLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NICLF + PFE for your $10,000?
Class 1 Nickel and Technologies Limited engages in the exploration and development of minerals and base metals in Canada. The company explores for nickel, copper, and cobalt sulphide deposits. It primarily holds a 100% interest in the Alexo-Dundonald project, comprising 95 Boundary Cell Mining Claims, Single Cell Mining Claims, Leased Claims, and Patented Claims, which covers an approximately 1,895 hectares located to the northeast of Timmins, Ontario. It also holds option to acquire 100% interest in the Somanike Project located in the Abitibi Region of Quebec, and 100% interest in the River Valley PGE Project located to northeastern Ontario, Canada. The company was formerly known as Legendary Ore Mining Corporation and changed its name to Class 1 Nickel and Technologies Limited in September 2019. Class 1 Nickel and Technologies Limited was incorporated in 1989 and is headquartered in Toronto, Canada.
Full NICLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.